Early HER2 positive breast cancer - trastuzumab emtansine - initial authority application form (PB289)

Use this form to apply for initial PBS-subsidised treatment with trastuzumab emtansine for early HER2 positive breast cancer.

Page last updated: 1 June 2025.
QC 52313